PSTI
Price:
$1
Market Cap:
$40.85M
Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also d...[Read more]
Industry
Biotechnology
IPO Date
2007-12-10
Stock Exchange
NASDAQ
Ticker
PSTI
According to Pluristem Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.68. This represents a change of -26.91% compared to the average of -0.94 of the last 4 quarters.
The mean historical PE Ratio of Pluristem Therapeutics Inc. over the last ten years is -4.85. The current -0.68 PE Ratio has changed 1.31% with respect to the historical average. Over the past ten years (40 quarters), PSTI's PE Ratio was at its highest in in the June 2025 quarter at 1.76. The PE Ratio was at its lowest in in the March 2018 quarter at -24.62.
Average
-4.85
Median
-4.75
Minimum
-7.93
Maximum
-2.06
Discovering the peaks and valleys of Pluristem Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 167.75%
Maximum Annual PE Ratio = -2.06
Minimum Annual Increase = -59.54%
Minimum Annual PE Ratio = -7.93
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -2.73 | 22.08% |
| 2021 | -2.23 | -59.54% |
| 2020 | -5.52 | 167.75% |
| 2019 | -2.06 | -58.32% |
| 2018 | -4.94 | 22.89% |
| 2017 | -4.02 | -11.60% |
| 2016 | -4.55 | -36.59% |
| 2015 | -7.18 | -2.45% |
| 2014 | -7.36 | -7.16% |
| 2013 | -7.93 | 10.95% |
The current PE Ratio of Pluristem Therapeutics Inc. (PSTI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.49
5-year avg
-3.50
10-year avg
-4.85
Pluristem Therapeutics Inc.’s PE Ratio is less than Magenta Therapeutics, Inc. (-0.02), less than Rein Therapeutics Inc. (-0.61), greater than Eyenovia, Inc. (-1.79), less than Satsuma Pharmaceuticals, Inc. (-0.51), greater than Lumos Pharma, Inc. (-2.41), less than Lunai Bioworks Inc. (-0.24), less than GreenLight Biosciences Holdings (-0.24), greater than Cerecor Inc. (-1.53), less than LianBio (4.68), greater than AlloVir, Inc. (-2.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.02 | $42.44M | |
| -0.61 | $35.71M | |
| -1.79 | $38.59M | |
| -0.51 | $36.47M | |
| -2.41 | $37.54M | |
| -0.24 | $32.92M | |
| -0.24 | $45.43M | |
| -1.53 | $38.63M | |
| 4.68 | $11.68M | |
| -2.14 | $49.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pluristem Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pluristem Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pluristem Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Pluristem Therapeutics Inc. (PSTI)?
What is the highest PE Ratio for Pluristem Therapeutics Inc. (PSTI)?
What is the 3-year average PE Ratio for Pluristem Therapeutics Inc. (PSTI)?
What is the 5-year average PE Ratio for Pluristem Therapeutics Inc. (PSTI)?
How does the current PE Ratio for Pluristem Therapeutics Inc. (PSTI) compare to its historical average?